Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Senators introduce bill aimed at getting generic drugs to market

Wednesday, June 15, 2016

Four US senators two Democrats and two Republicans introduced a bill on Tuesday aimed at preventing big pharmaceutical companies from using safety rules to prevent generic drugs from coming to market Senators Charles Grassley chair of the Judiciar...

Shire buys bowel drug rights from Pfizer

Wednesday, June 15, 2016

Irish drugmaker Shire Plc said it would buy the rights to an experimental bowel drug from Pfizer Inc to bolster its pipeline of gastrointestinal treatments The drug PF which is designed to treat moderatetosevere inflammatory bowel disease has succes...

Novartis expands partnership with Medicines for Malaria Venture to develop next-generation antimalarial treatment

Wednesday, June 15, 2016

Novartis announced today that it will further expand its longstanding partnership with Medicines for Malaria Venture MMV Novartis will lead the development of antimalarial compound KAF with scientific and financial support from MMV in collaboration w...

Marinus' drug for focal onset seizures fails in late-stage study

Tuesday, June 14, 2016

Marinus Pharmaceuticals Inc said it plans to discontinue a clinical program testing its experimental treatment for drugresistant focal onset seizures in adults after it failed in a latestage trial The study testing the drug ganaxolone missed the mai...

NPPA issues notices to drug companies over violations of DPCO 2013

Tuesday, June 14, 2016

Taking a serious view of noncompliance of DPCO the National Pharmaceutical Pricing Authority NPPA has issued notices to major drug firms for failing to register products on online database IPDMS and not filing mandatory returns through it The autho...

Mesoblast regains full rights to stem cell heart failure treatment

Tuesday, June 14, 2016

Mesoblast Ltd on Monday said it had regained full rights to its experimental stem cell therapy for advanced chronic heart failure which is currently in late stage testing from Teva Pharmaceutical Industries While Teva returned its rights to the pote...

Novo diabetes drug cuts heart risks by 13 percent in key trial

Tuesday, June 14, 2016

Novo Nordisks topselling diabetes drug Victoza cut the risk of heart attack stroke and cardiovascular death by percent in a closely watched study that may help boost sales of the injectable medicine Victoza is only the second diabetes drug to show...

India's Dr Reddy's in $350 million deal to buy eight U.S. drugs from Teva, Allergan

Monday, June 13, 2016

Indias secondlargest drugmaker Dr Reddys Laboratories Ltd said it agreed to buy eight generic drugs from Teva Pharmaceutical Industries and Allergan Plc for million in cash to bolster its US business The deal is among Dr Reddys biggest acquisitions...

Zealand Pharma: Positive results from pivotal Phase III clinical trials with iGlarLixi

Monday, June 13, 2016

Zealand Pharma AS Positive results from pivotal Phase III clinical trials with iGlarLixi Type diabetes patients treated with iGlarLixi formerly LixiLan had significantly greater reductions in blood glucose HbAc versus treatment with either lixisena...

Sanofi says LixiLan diabetes drug trials meet targets

Monday, June 13, 2016

Frances Sanofi said on Sunday that two latestage Phase III clinical trials of its LixiLan diabetes drug had met their targets readying it for approval in the United States in August and Europe early next year LixiLan consists of a singleinjection co...